LEAH PHILPOT: Open Payments
NPI 1720832033 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,250 in 73 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $248 · 2025 $2,250
Food & beverage: $2,150Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $770 |
| GENZYME CORPORATION | 10 | $271 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $200 |
| CSL Behring | 13 | $189 |
| Regeneron Healthcare Solutions, Inc. | 6 | $168 |
| GlaxoSmithKline, LLC. | 7 | $160 |
| Novartis Pharmaceuticals Corporation | 5 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $141 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Ionis Pharmaceuticals, Inc. | 2 | $40 |
Products named: DUPIXENT, TEZSPIRE, NEFFY, FASENRA, AIRSUPRA, BREZTRI, XOLAIR, TAKHZYRO.
Industry payments across FL — which companies pay providers there.
